methazolamide has been researched along with Insulin Resistance in 1 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konstantopoulos, N | 1 |
| Molero, JC | 1 |
| McGee, SL | 1 |
| Spolding, B | 1 |
| Connor, T | 1 |
| de Vries, M | 1 |
| Wanyonyi, S | 1 |
| Fahey, R | 1 |
| Morrison, S | 1 |
| Swinton, C | 1 |
| Jones, S | 1 |
| Cooper, A | 1 |
| Garcia-Guerra, L | 1 |
| Foletta, VC | 1 |
| Krippner, G | 1 |
| Andrikopoulos, S | 1 |
| Walder, KR | 1 |
1 other study available for methazolamide and Insulin Resistance
| Article | Year |
|---|---|
Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo.
Topics: Animals; Blood Glucose; Carbonic Anhydrase Inhibitors; Diabetes Mellitus, Experimental; Glucose Clam | 2012 |